Design Therapeutics, Inc.

NASDAQ:DSGN

Biotechnology

Healthcare
$9.84 +1.59%

+$0.19 today

Market cap
$630.12M
Beta
1.66
P/E (TTM)
-10.7
EPS (TTM)
-$1.13
52W Low $3.33High $17.25

Volume 0.29M

Average 0.74M

Price history

Design Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+29.64%

Period high

$15.94

Period low

$7.34

Latest

$9.84

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
EFFECTNov 12, 2026Nov 13, 2026
S-3Nov 4, 2026Nov 4, 2026
8-KNov 4, 2026Nov 4, 2026
10-QNov 4, 2026Nov 4, 2026
424B5Nov 4, 2026Nov 4, 2026
SC 13GAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
8-KAug 3, 2026Aug 3, 2026
10-QAug 3, 2026Aug 3, 2026
4Jun 11, 2026Jun 11, 2026
4Jun 11, 2026Jun 11, 2026
4Jun 11, 2026Jun 11, 2026
4Jun 11, 2026Jun 11, 2026
4Jun 11, 2026Jun 11, 2026
8-KJun 11, 2026Jun 11, 2026

Competitors

Who does Design Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about DSGN's filings, answered from its disclosures.

What is the latest DSGN filing?

The latest filing shown is EFFECT dated Nov 12, 2026.

How many recent filings does DSGN have?

Intrinsic Alpha currently shows 20 recent filings for DSGN.